Your shopping cart is currently empty

LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,570 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $3,380 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $4,600 | 10-14 weeks | 10-14 weeks |
| Description | LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells. |
| Targets&IC50 | mGluR3:1.05 μM, mGluR2:0.161 μM |
| In vivo | LY 541850 (intraperitoneal injection;?10 mg/kg-300 mg/kg;?30 min prior) reduces the increased locomotor activity of phencyclidine and amphetamine in a dose-dependent manner in male ICR mice[1]. |
| Molecular Weight | 199.2 |
| Formula | C9H13NO4 |
| Cas No. | 852679-76-6 |
| Smiles | C(O)(=O)[C@@]1(N)[C@]2([C@]([C@@H]2C(O)=O)([C@H](C)C1)[H])[H] |
| Relative Density. | 1.443 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.